SecBot SecBot
3 ·Filed Sep 3, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001193125-26-382268
Form 3, initial insider ownership statement
Actionable Insight • Neutral

No immediate trading signal. Monitor future Form 4 filings from Patni for any open-market purchases or sales, which would provide insider conviction signals. The appointment itself is neutral for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$36.75
T+0 close · Sep 3, 2026 · via day close
Latest settled
+3.05%
T+20 · $37.87 · next T+60 in 14d
Vs SPY
+2.45%
α at T+20
Latest observation
+34.15%
T+49 · FF3 residual α
  1. T+0 · Sep 4 $36.75entry
  2. T+1 · 2mo ago +1.69%α +2.24% · $37.37
  3. T+5 · 2mo ago +7.62%α +8.83% · $39.55
  4. T+20 · 6w ago +3.05%α +2.45% · $37.87
  5. T+50 · todayOpen
  6. T+60 · in 14d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Rajiv Patni, M.D., has been appointed Chief Medical Officer of Septerna, Inc. and filed a Form 3 initial statement of beneficial ownership, along with a limited power of attorney authorizing certain company officers to execute future Section 16 filings on his behalf. This is a routine administrative filing for a new officer and contains no financial data, trading activity, or material corporate event.

Key Facts

  • Rajiv Patni, M.D. appointed as Chief Medical Officer of Septerna, Inc.
  • Form 3 filed on 2026-09-03 with a period of report of 2026-08-24
  • Limited power of attorney executed on 2026-08-18 authorizing Jeffrey Finer, Elizabeth Bhatt, Gil M. Labrucherie, Mark A. Wilson, and Ran Xiao to file Section 16 forms
  • No beneficial ownership or trading data disclosed in the filing

Financial Impact

No financial impact, routine officer onboarding filing with no disclosed ownership or transactions.

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-382268
Document: 0001193125-26-382268-index-headers.html0001193125-26-382268
Document: 0001193125-26-382268-index.html0001193125-26-382268
Document: 0001193125-26-382268.txt0001193125-26-382268

Track record

25 reports on SEPN

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  3. Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
  5. Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $42.60 +1.77% settles Nov 19
  6. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $42.60 +18.61% settles Nov 17
  7. Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
  9. Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $42.60 +10.62% ▲ +0.47% +0.69% vs SPY
  10. Sep 3, 202610w ago 3 Neutral 2/10 Viewing Entry $36.75 to $39.55 Now $42.60 +15.92% ▲ +7.62% +8.83% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 3, 2026